Literature DB >> 9876676

No scalpel, no iv, no stitch, microendoscopic office laparoscopy under local anesthesia.

B R Love, R McCorvey.   

Abstract

BACKGROUND: The medical literature is replete with articles verifying the usefulness of laparoscopic procedures under local anesthesia. Recent research has examined the efficacy of microendoscopy with local anesthesia. In this series of patients, we focused on new technology to determine if microendoscopy could be utilized in an office setting.
METHODS: Between July 1994 and April 1995, we performed 51 microendoscopic office laparoscopy under local anesthesia (MICRO-OLULA) using the 1.5 mm Pixie laparoscope by Origin, a 1.7 mm laparoscope by Optimed and 5 mm laparoscope by Jarit. All cases were performed in an office operating room at the Women's Medical Plaza in Montgomery, Alabama. Only one patient was unable to have the procedure completed due to intolerance under local anesthesia.
RESULTS: Fifty-one micro-olulas were performed on these patients who had an average age of 31 years and an average weight of 157 pounds. Intraoperative abdominal time averaged 3 minutes. One case was done with a 5 mm laparoscope and five cases with the 1.7 mm Optimed laparoscope. The 1.5 mm Pixie laparoscope was used in 45 patients.
CONCLUSIONS: Our patients seemed to like the idea of a small device to view their pelvic cavities. The small laparoscopes provide excellent cosmesis, and laparoscopes deserve further development and clinical trial to determine their most advantageous use in the office setting.

Entities:  

Mesh:

Year:  1997        PMID: 9876676      PMCID: PMC3016721     

Source DB:  PubMed          Journal:  JSLS        ISSN: 1086-8089            Impact factor:   2.172


INTRODUCTION

The medical literature is replete with articles verifying the usefulness of laparoscopic procedures under local anesthesia.[1, 2] Recent research has examined the efficacy of microendoscopy with local anesthesia.[4-8] In this series of patients, we focused on new technology to determine if microendoscopy could be utilized in an office setting and to evaluate the patient's pain responses to various aspects of micro-olula.[3] Between July 1994 and April 1995, we performed 51 microendoscopic office laparoscopy under local anesthesia (MICRO-OLULA) using the 1.5 mm Pixie laparoscope by Origin, a 1.7 mm laparoscope by Optimed and 5 mm laparoscope by Jarit. All cases were performed in an office operating room at the Women's Medical Plaza in Montgomery, Alabama. In a previous publication, we have already demonstrated the efficacy and the economic benefits of office laparoscopy. Only one patient was unable to have the procedure completed due to intolerance under local anesthesia. All patients were evaluated preoperatively with a complete history and physical exam, viewed a video on laparoscopy under local anesthesia and given the Belly test.[1,9] Basic operative technique was similar to our previously published office laparoscopy cases: i.e., intramuscular preop meds, field block anesthesia at the umbilicus and a paracervical block.[1,9] Intravenous access was not used in this group of patients. IV fluids, however, were in the operating room if needed. Carbon dioxide gas was used to insufflate all patients.

RESULTS

Fifty-one micro-olulas were performed on these patients who had an average age of 31 years and an average weight of 157 pounds. Intraoperative abdominal time averaged 3 minutes. One case was done with a 5 mm laparoscope and five cases with the 1.7 mm Optimed laparoscope. We used the 1.5 mm Pixie laparoscope in 45 patients. See for the various pathologies found in these micro-olula cases. Several patients had multiple pathologies. Micro-olula pathology. We obtained pain data in 29 patients using the pain survey by Fishburne from an earlier paper. Similar to Fishburne's original work, we evaluated our patient's pain response to six parts of the procedure using a scale from 0 to 4 (0 = no pain, 1 = slight pain, 2 = moderate pain, 3 = severe pain, 4 = extremely severe pain). For this study we evaluated the patient's response to the paracervical block, skin evaluation, CO2 gas insufflation, trocar insertion, uterine motion and Fallopian tube pain (). Most of the surveyed patients had minimal postoperative complaints of nausea, vomiting, syncope and other difficulties (). Patients' Responses. Postoperative complaints

DISCUSSION

The small laparoscope seemed to appeal to patients. Only two patients of this series said that they would not recommend micro-olula to a friend. The remainder of the patients said that they would highly recommend micro-olula to their friends. Fishburne's pain survey suggested that the most painful aspect of micro-olula was movement of the uterus. It is possible, however, that painful uterine motion may be related to anxiety or pelvic pathology. From our small series of patients it appears that the pain associated with micro-olula is minimal. From our initial experiences with microendoscopes, we believe that clinicians can readily utilize diagnostic laparoscopy in an office setting. In the near future, we plan to do more micro-olula with two punctures to assess pelvic pain patients, adhesiolysis and patients needing assisted reproductive technology (ART).[10-13] Ultimately, micro-olula technique may permit us to evaluate pelvic pain patients in the office with little preparation of the patient. We do not believe that patient safety is compromised by using a no IV technique since we had IVs available in the office operating room and had extensive experience in performing office laparoscopy. The no IV technique is not recommended for those beginning their experience with office laparoscopy. There are disadvantages associated with micro-olulas including a small field of view and decreased magnification with small laparoscopes. The Pixie laparoscope has potential for use in an office setting but may be limited due to cost concerns. Our patients seemed to like the idea of a small device to view their pelvic cavities. The small laparoscopes provide excellent cosmesis. Microendoscopes deserve further development and clinical trials, to determine their most advantageous use in the office setting.
Table 1.

Micro-olula pathology.

PATHOLOGYNUMBER OF PATIENTS
Fibroids17
Pelvic adhesions10
Benign ovarian cysts7
Endometriosis5
PCO4
PID3
Fitz-Hugh-Curtis Syndrome1
Table 2.

Patients' Responses.

Average response
Uterine motion2.5
Skin elevation2.0
Insufflation1.68
Paracervical block1.2
Fallopian tube pain0.63
Trocar insertion0.52
Table 3.

Postoperative complaints

YesNo
Nausea14%86%
Vomiting7%93%
Syncope7%93%
  9 in total

1.  The needlescope and other small diameter laparoscopes for sterilization and diagnostic procedures.

Authors:  J R Dingfelder; W E Brenner
Journal:  Int J Gynaecol Obstet       Date:  1976       Impact factor: 3.561

2.  Low-cost office laparoscopic sterilization.

Authors:  B R Love; R McCorvey; M McCorvey
Journal:  J Am Assoc Gynecol Laparosc       Date:  1994-08

3.  Laparoscopic zygote intrafallopian transfer using augmented local anesthesia.

Authors:  J J Waterstone; V N Bolton; M Wren; J H Parsons
Journal:  Fertil Steril       Date:  1992-02       Impact factor: 7.329

4.  Office laparoscopic sterilization with local anesthesia.

Authors:  J I Fishburne
Journal:  J Reprod Med       Date:  1977-05       Impact factor: 0.142

5.  Microlaparoscopy: a preliminary report.

Authors:  F Risquez; G Pennehouat; R Fernandez; E Confino; O Rodriguez
Journal:  Hum Reprod       Date:  1993-10       Impact factor: 6.918

6.  The diagnostic accuracy of a microlaparoscope.

Authors:  D Molloy
Journal:  J Am Assoc Gynecol Laparosc       Date:  1995-02

7.  Office microlaparoscopy under local anesthesia for chronic pelvic pain.

Authors:  S F Palter; D L Olive
Journal:  J Am Assoc Gynecol Laparosc       Date:  1996-05

8.  Use of optical catheters for diagnostic office laparoscopy.

Authors:  J R Feste
Journal:  J Reprod Med       Date:  1996-05       Impact factor: 0.142

9.  Repeated clinic laparoscopy for the treatment of pelvic adhesions: a pilot study.

Authors:  J F Steege
Journal:  Obstet Gynecol       Date:  1994-02       Impact factor: 7.661

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.